NIH-funded research R01 grant

How tuberculosis spreads in the body

Official title: Mathematical modeling of Mycobacterium tuberculosis dissemination

Funded at Texas Biomedical Research Institute · NIH-11326688 · Data updated 2026-11-12

Researchers are using mouse experiments plus computer models to learn how TB moves from the lung to other parts of the body, aiming to help children and people with weakened immune systems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Biomedical Research Institute
NIH-funded
Lab location1 site (San Antonio, United States)
Project startApril 22, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$685,991
NIH project number5R01AI158963-05
Project IDNIH-11326688 on NIH RePORTER

Who could benefit from this research

Could help

People with active TB or those at high risk for TB spread—for example young children and immunocompromised adults—would be the most relevant candidates for related studies or future trials.

Less likely to help

People without TB or those with lung conditions unrelated to tuberculosis are unlikely to receive direct benefit from this project.

What this research studies

From a patient point of view, the team infects mice with very tiny amounts of TB bacteria and tracks many uniquely 'barcoded' bacterial strains to see where they go. They use a genetic 'replication clock' in the bacteria to estimate how fast bacteria are cleared in the body. They also link patterns of mouse infection to mRNA gene signatures that can predict bacterial levels and disease risk in people. Combining lab, animal, and computational work aims to give a clearer picture of why TB spreads in some patients and not others.

Why it matters

Potential benefit: If successful, this work could help doctors detect and treat TB that spreads beyond the lung earlier, especially in children and immunocompromised patients.

How similar studies have gone: Previous animal-model and molecular-signature studies have provided useful insights into TB, but combining ultra-low-dose barcoded infections, bacterial replication clocks, and human mRNA risk signatures is a novel integrated approach.

Where this research is happening

  • Texas Biomedical Research Institute
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Ganusov, Vitaly V. — Texas Biomedical Research Institute
  • Study coordinator: Ganusov, Vitaly V.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.